Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: Initial U.S. feasibility trial using the Duett vascular closure device

Mooney, M.; Ellis, Stephen G.; Gershony, Gary; Yehyawi, Kais J.; Kummer, Barbara; Lowrie, Marsha

doi:10.1002/(sici)1522-726x(200005)50:1<96::aid-ccd21>3.0.co;2-v

Cited by 32 publications

(9 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Duett device has been shown to be effective in achieving satisfactory hemostasis and early ambulation compared with manual compression. [19][20][21] Vessels, which have been treated with the Duett closure device, can undergo repeated puncture immediately for angiography and cause minimal local inflammation. Potential accidental injection of collagen into intraluminal space can occur due to suboptimal balloon inflation.…”

Section: Figmentioning

confidence: 99%

“…12,19,20,54-57 Similar treatment success was also reported in patients who received full anticoagulation. 21,54 Other studies noted no differences in terms of complications, including femoral artery pseudoaneurysm, hematoma, or groin infection, between patients treated with the Duett device vs those treated with manual compression. 19,21 In the event of an unusual complication of a femoral artery thrombosis following the deployment of the Duett device, successful flow restoration has been reported using catheter-directed thrombolytic therapy.…”

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

“…21,54 Other studies noted no differences in terms of complications, including femoral artery pseudoaneurysm, hematoma, or groin infection, between patients treated with the Duett device vs those treated with manual compression. 19,21 In the event of an unusual complication of a femoral artery thrombosis following the deployment of the Duett device, successful flow restoration has been reported using catheter-directed thrombolytic therapy. 21,55 As the first approved device using a suture-mediated technology, the Perclose device was viewed by many as a technology utilizing many cumbersome steps for suture deployment and knot creation.…”

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

“…19,21 In the event of an unusual complication of a femoral artery thrombosis following the deployment of the Duett device, successful flow restoration has been reported using catheter-directed thrombolytic therapy. 21,55 As the first approved device using a suture-mediated technology, the Perclose device was viewed by many as a technology utilizing many cumbersome steps for suture deployment and knot creation. While several clinical studies reported device success rates ranging from 90% to 100% which is similar to other devices.…”

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

See 3 more Smart Citations

Access site management with vascular closure devices for percutaneous transarterial procedures

Bechara

Annambhotla

Lin

2010

Journal of Vascular Surgery

View full text Add to dashboard Cite

The rising numbers in the aging population will undoubtedly lead to a corresponding increase in percutaneous endovascular procedures to address their cardiovascular health issues. With a constant drive to develop innovative treatment methods to achieve improved treatment outcomes while reducing procedural-related complications, endovascular interventionalists have focused on technologies to provide efficient hemostatic control of femoral artery access following percutaneous diagnostic or therapeutic angiographic procedures. Compared with the traditional hemostatic method using manual compression, several arterial closure devices (ACD) have been shown to reduce time of hemostasis, enable early patient ambulation, reduce hospitalization staff use, and improve patient outcome. However, these ACDs have their shortcomings as the interventionalists need to be familiar with these technologies as well as their potential complications. This article provides a comprehensive review of current closure device technologies as well as clinical experiences with these devices. The adjunctive role of these technologies in endovascular aortic aneurysm repair is also discussed.

show abstract

Section: Figmentioning

confidence: 99%

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

Section: Clinical Experience With Vascular Closure Devicesmentioning

confidence: 99%

See 2 more Smart Citations

Access site management with vascular closure devices for percutaneous transarterial procedures

Bechara

Annambhotla

Lin

2010

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…Rates of successful deployment have been quite high ranging from 93% to 100% [25][26][27][28]. When compared with manual compression, the time to hemostasis and ambulation were significantly decreased when the Duett device was employed [29,30].…”

Section: The Duett Devicementioning

confidence: 99%